1. Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
   Ali Khosravi et al, 2019, Molecular Medicine CrossRef
2. Gasotransmitters in cancer: from pathophysiology to experimental therapy
   Csaba Szabo, 2016, Nature Reviews Drug Discovery CrossRef
3. Senescence as a main mechanism of Ritonavir and Ritonavir‐NO action against melanoma
   Svetlana Paskaš et al, 2019, Molecular Carcinogenesis CrossRef
4. Emerging targeted therapies for melanoma treatment (Review)
   ANGELA RUSSO et al, 2014, International Journal of Oncology CrossRef
5. Saquinavir‐NO Inhibits IL‐6 Production in Macrophages
   Miljana Momčilović et al, 2014, Basic & Clinical Pharmacology & Toxicology CrossRef
6. Gasotransmitters and the immune system: Mode of action and novel therapeutic targets
   Paolo Fagone et al, 2018, European Journal of Pharmacology CrossRef
7. Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo
   Svetlana Paskas et al, 2019, Investigational New Drugs CrossRef
8. The Double-Faced Role of Nitric Oxide and Reactive Oxygen Species in Solid Tumors
   Sanja Mijatović et al, 2020, Antioxidants CrossRef
9. Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity
   Tomas Koltai, 2015, F1000Research CrossRef
10. HIV‐protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO‐hybridized derivatives?
    Danijela Maksimovic‐Ivanic et al, 2017, International Journal of Cancer CrossRef
11. Role of lactic acid on cognitive functions
    Marinella Coco et al, 2019, The Physician and Sportsmedicine CrossRef
12. Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
    Eugenio Cavalli et al, 2020, Molecules CrossRef
13. Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir
    Paolo Fagone et al, 2015, Basic & Clinical Pharmacology & Toxicology CrossRef
14. The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K
    Danijela Maksimovic-Ivanic et al, 2015, Leukemia Research CrossRef